Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125456821 | 12545682 | 1 | I | 201602 | 20160701 | 20160711 | 20160711 | EXP | FR-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000263 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125456821 | 12545682 | 1 | PS | Coversyl | PERINDOPRIL | 1 | Oral | 8 MG, QD | Y | U | UNKNOWN | 20184 | 8 | MG | TABLET | ||||
| 125456821 | 12545682 | 2 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Unknown | 200 MG, UNK | Y | U | UNKNOWN | 0 | 200 | MG | TABLET | ||||
| 125456821 | 12545682 | 3 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, BID | Y | U | UNKNOWN | 0 | 200 | MG | TABLET | ||||
| 125456821 | 12545682 | 4 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Unknown | 20 MG, UNK | Y | U | UNKNOWN | 0 | 20 | MG | TABLET | ||||
| 125456821 | 12545682 | 5 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | Y | U | UNKNOWN | 0 | 20 | MG | TABLET | ||||
| 125456821 | 12545682 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | UNKNOWN | 0 | |||||||||
| 125456821 | 12545682 | 7 | C | PREVISCAN /00789001/ | FLUINDIONE | 1 | UNK | U | UNKNOWN | 0 | |||||||||
| 125456821 | 12545682 | 8 | C | XATRAL | ALFUZOSIN | 1 | UNK | U | UNKNOWN | 0 | |||||||||
| 125456821 | 12545682 | 9 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125456821 | 12545682 | 1 | Hypertension |
| 125456821 | 12545682 | 2 | Atrial flutter |
| 125456821 | 12545682 | 4 | Dyslipidaemia |
| 125456821 | 12545682 | 6 | Product used for unknown indication |
| 125456821 | 12545682 | 7 | Product used for unknown indication |
| 125456821 | 12545682 | 8 | Product used for unknown indication |
| 125456821 | 12545682 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125456821 | 12545682 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125456821 | 12545682 | Atrial fibrillation | |
| 125456821 | 12545682 | Cardiac failure | |
| 125456821 | 12545682 | Organising pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125456821 | 12545682 | 1 | 201311 | 20160222 | 0 | |
| 125456821 | 12545682 | 2 | 201412 | 201511 | 0 | |
| 125456821 | 12545682 | 3 | 20160126 | 20160222 | 0 | |
| 125456821 | 12545682 | 4 | 201508 | 201511 | 0 | |
| 125456821 | 12545682 | 5 | 20160126 | 20160228 | 0 | |
| 125456821 | 12545682 | 6 | 201311 | 0 | ||
| 125456821 | 12545682 | 7 | 201311 | 0 | ||
| 125456821 | 12545682 | 8 | 201311 | 0 | ||
| 125456821 | 12545682 | 9 | 201311 | 0 |